Literature DB >> 7447493

PUVA-treatment for solar urticaria and persistent light reaction.

E Hölzle, C Hofmann, G Plewig.   

Abstract

A technique is described to successfully treat patients with extreme sensitivity to UV electromagnetic wave lengths with photochemotherapy. Representative data from a patient with solar urticaria and two patients with persistent light reaction are given. Prior to treatment the threshold doses for UV-C, UV-B, and UV-A were determined. Photochemotherapy was performed with standard 8-methoxypsoralen-UV-A (PUVA) schedules. Initial treatments were very difficult because of the extreme UV-sensitivity in all patients. Once pigmentation was induced, PUVA-treatments were easy to perform. All patients became almost free of symptoms and were able, for the first time in years, to resume normal outdoor activities. Remission was long-lasting. Photochemotherapy is offered as a new effective means to alleviate the symptoms of disabling photodermatoses.

Entities:  

Mesh:

Year:  1980        PMID: 7447493     DOI: 10.1007/bf00404462

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  Oral methoxsalen photochemotherapy of uncommon photodermatoses.

Authors:  W L Morison; H A White; E Gonzalez; J A Parrish; T B Fitzpatrick
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

2.  Solar urticaria treatment by inducing tolerance to artificial radiation and natural light.

Authors:  C A Ramsay
Journal:  Arch Dermatol       Date:  1977-09

3.  [Photochemotherapy in mycosis fungoides].

Authors:  K Konrad; F Gschnait; H Hönigsmann; P Fritsch; K Wolff
Journal:  Hautarzt       Date:  1978-04       Impact factor: 0.751

4.  Oral carotene therapy in actinic reticuloid and solar urticaria. Failure to demonstrate a photoprotective effect against long wave ultraviolet and visible radiation.

Authors:  A Kobza; C A Ramsay; I A Magnus
Journal:  Br J Dermatol       Date:  1973-02       Impact factor: 9.302

5.  [The testing of photochemotherapy in various dermatoses].

Authors:  W Brenner; F Gschnait; H Hönigsmann; P Fritsch
Journal:  Hautarzt       Date:  1978-10       Impact factor: 0.751

6.  A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications.

Authors:  M F Mutzhas; E Hölzle; C Hofmann; G Plewig
Journal:  J Invest Dermatol       Date:  1981-01       Impact factor: 8.551

7.  Induction of UV light tolerance by PUVA in patients with polymorphous light eruption.

Authors:  F Gschnait; H Hönigsmann; W Brenner; P Fritsch; K Wolff
Journal:  Br J Dermatol       Date:  1978-09       Impact factor: 9.302

8.  Photoprotective effect of a psoralen-UVA-induced tan.

Authors:  F Gschnait; W Brenner; K Wolff
Journal:  Arch Dermatol Res       Date:  1978-11-10       Impact factor: 3.017

9.  Photochemotherapy for mycosis fungoides: a clinical and histological study.

Authors:  N J Lowe; D J Cripps; P A Dufton; C F Vickers
Journal:  Arch Dermatol       Date:  1979-01

10.  [Pityriasis lichenoides chronica--a new indication for PUVA therapy? (author's transl)].

Authors:  C Hofmann; I Weissmann; G Plewig
Journal:  Dermatologica       Date:  1979
View more
  3 in total

Review 1.  [Solar urticaria].

Authors:  S Schauder
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 2.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

3.  Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study.

Authors:  J H Olafsson; O Larkö; G Roupe; G Granerus; U Bengtsson
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.